Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Kun-Liang Guan
Affiliation
University of California San Diego
ORCID
Career Start Year
1988
Papers
432
H Index
145
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36919698
The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune response.
J Clin Invest
2023
37932786
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
Mol Cancer
2023
37739954
YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis.
Nat Commun
2023
37580748
Correction: Reprogramming anchorage dependency by adherentâ¿¿toâ¿¿suspension transition promotes metastatic dissemination.
Mol Cancer
2023
37308716
Insights into recent findings and clinical application of YAP and TAZ in cancer.
Nat Rev Cancer
2023
36998106
The Arf family GTPases: Regulation of vesicle biogenesis and beyond.
Bioessays
2023
37115931
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy.
Sci Adv
2023
36991428
Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination.
Mol Cancer
2023
36919698
The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune response.
J Clin Invest
2023
37739954
YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis.
Nat Commun
2023
37580748
Correction: Reprogramming anchorage dependency by adherentâ¿¿toâ¿¿suspension transition promotes metastatic dissemination.
Mol Cancer
2023
37932786
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
Mol Cancer
2023
36991428
Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination.
Mol Cancer
2023
37115931
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy.
Sci Adv
2023
37308716
Insights into recent findings and clinical application of YAP and TAZ in cancer.
Nat Rev Cancer
2023
36998106
The Arf family GTPases: Regulation of vesicle biogenesis and beyond.
Bioessays
2023
34265423
The two sides of Hippo pathway in cancer.
Semin Cancer Biol
2022
35844135
Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.
EMBO J
2022
36348011
TET2 deficiency sensitizes tumor cells to statins by reducing HMGCS1 expression.
Oncogene
2022
36347846
The Hippo signalling pathway and its implications in human health and diseases.
Signal Transduct Target Ther
2022
35613278
The Hippo pathway mediates Semaphorin signaling.
Sci Adv
2022
36064579
ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3.
Oncogene
2022
35788180
Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides.
Nat Chem Biol
2022
36319062
Tanshinone functions as a coenzyme that confers gain of function of NQO1 to suppress ferroptosis.
Life Sci Alliance
2022
35535466
The multifaceted role of autophagy in cancer.
EMBO J
2022
36400006
Acetyl-CoA, protein acetylation, and liver cancer.
Mol Cell
2022
36446024
A Class of Disulfide Compounds Suppresses Ferroptosis by Stabilizing GPX4.
ACS Chem Biol
2022
35535164
Protocols for measuring phosphorylation, subcellular localization, and kinase activity of Hippo pathway components YAP and LATS in cultured cells.
STAR Protoc
2022
34265423
The two sides of Hippo pathway in cancer.
Semin Cancer Biol
2022
35294906
Rheb regulates nuclear mTORC1 activity independent of farnesylation.
Cell Chem Biol
2022
35292350
Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis.
J Hepatol
2022
35256775
Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses.
Nat Cell Biol
2022
35217640
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER<sup>+</sup> breast cancer.
Nat Commun
2022
34706158
Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence.
Mol Oncol
2022
35177479
Rag GTPases regulate cellular amino acid homeostasis.
Proc Natl Acad Sci U S A
2022
35844135
Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.
EMBO J
2022
35613278
The Hippo pathway mediates Semaphorin signaling.
Sci Adv
2022
35535466
The multifaceted role of autophagy in cancer.
EMBO J
2022
35535164
Protocols for measuring phosphorylation, subcellular localization, and kinase activity of Hippo pathway components YAP and LATS in cultured cells.
STAR Protoc
2022
35788180
Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides.
Nat Chem Biol
2022
36446024
A Class of Disulfide Compounds Suppresses Ferroptosis by Stabilizing GPX4.
ACS Chem Biol
2022
36400006
Acetyl-CoA, protein acetylation, and liver cancer.
Mol Cell
2022
36064579
ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3.
Oncogene
2022
36348011
TET2 deficiency sensitizes tumor cells to statins by reducing HMGCS1 expression.
Oncogene
2022
36347846
The Hippo signalling pathway and its implications in human health and diseases.
Signal Transduct Target Ther
2022
36319062
Tanshinone functions as a coenzyme that confers gain of function of NQO1 to suppress ferroptosis.
Life Sci Alliance
2022
35256775
Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses.
Nat Cell Biol
2022
35217640
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER<sup>+</sup> breast cancer.
Nat Commun
2022
35177479
Rag GTPases regulate cellular amino acid homeostasis.
Proc Natl Acad Sci U S A
2022
35294906
Rheb regulates nuclear mTORC1 activity independent of farnesylation.
Cell Chem Biol
2022
1 - 50 of 864
Column Actions
Search
Recommended Authors
Alexandre Rosa Campos
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2015
Number of shared co-authors
3
Min Gao
College of Horticulture, China Agricultural University
Career Start Year
2012
Number of shared co-authors
1
Florent Dingli
Institut Curie, PSL Research University
Career Start Year
2011
Number of shared co-authors
2
Joseph Tcherkezian
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Career Start Year
2004
Number of shared co-authors
0
Genevi??ve Lavoie
Institute for Research in Immunology and Cancer (IRIC)
Career Start Year
2004
Number of shared co-authors
2
Barak Rotblat
Ben-Gurion University of the Negev
Career Start Year
2002
Number of shared co-authors
10
Yong Jae Shin
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Career Start Year
2001
Number of shared co-authors
1
Hye Jin You
Research Institute, National Cancer Center
Career Start Year
2000
Number of shared co-authors
0
Arnaud Besson
University of Toulouse, CNRS
Career Start Year
1999
Number of shared co-authors
0
Rachel Toth
University of Dundee
Career Start Year
1999
Number of shared co-authors
3
Stephane Angers
Department of Pharmaceutical Sciences, University of Toronto
Career Start Year
1999
Number of shared co-authors
4
Philippe P Roux
IRIC - University of Montreal
Career Start Year
1998
Number of shared co-authors
2
Brian James
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1995
Number of shared co-authors
2
Mingyao Liu
The Institute of Biomedical Sciences, East China Normal University
Career Start Year
1994
Number of shared co-authors
1
Michael A White
University of Georgia
Career Start Year
1994
Number of shared co-authors
4
Anne-Claude Gingras
Lunenfeld-Tanenbaum Research Institute
Career Start Year
1994
Number of shared co-authors
9
Brian Raught
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1994
Number of shared co-authors
6
Jiefei Tong
Hospital for Sick Children
Career Start Year
1993
Number of shared co-authors
1
John Alan Diehl
Case Western Reserve University School of Medicine
Career Start Year
1993
Number of shared co-authors
7
Christoph Reinhard
Lilly Research Laboratories
Career Start Year
1992
Number of shared co-authors
2
Dario R Alessi
University of Dundee
Career Start Year
1992
Number of shared co-authors
1
Dirk Geerts
Amsterdam University Medical Center
Career Start Year
1989
Number of shared co-authors
1
Rosalie C Sears
Oregon Health and Science University
Career Start Year
1987
Number of shared co-authors
5
Michael F Moran
Hospital for Sick Children, University of Toronto
Career Start Year
1985
Number of shared co-authors
2
Sylvain Meloche
Institute for Research in Immunology and Cancer
Career Start Year
1982
Number of shared co-authors
2
James R Woodgett
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year
1982
Number of shared co-authors
6
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1981
Number of shared co-authors
11
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year
1979
Number of shared co-authors
10
Frank McCormick
Frederick National Laboratory for Cancer Research
Career Start Year
1975
Number of shared co-authors
10
Tony Hunter
Salk Institute for Biological Studies
Career Start Year
1968
Number of shared co-authors
11
row(s) 1 - 30 of 30
Collaborators
Zhipeng Meng
University of Miami Miller School of Medicine
Co-authored papers
26
Fa-Xing Yu
Institute of Pediatrics, Children's Hospital of Fudan University
Co-authored papers
25
Steven W Plouffe
University of California
Co-authored papers
23
Cun-Yu Wang
University of California, Los Angeles (university of california los angeles)
Co-authored papers
20
Toshiro Moroishi
Kumamoto University
Co-authored papers
18
Hyun Woo Park
College of Life Science and Biotechnology, Yonsei University
Co-authored papers
16
Jack E Dixon
University of California
Co-authored papers
16
Audrey W Hong
Stanford University School of Medicine
Co-authored papers
11
Kimberly C Lin
University of California san francisco
Co-authored papers
10
Michael Karin
Co-authored papers
6
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers
5
Mengtao Xiao
Co-authored papers
5
Bing Ren
Center for Epigenomics, University of California San Diego
Co-authored papers
5
Jiahuai Han
Co-authored papers
4
Yunjiang Qiu
Ludwig Institute for Cancer Research, University of California
Co-authored papers
4
Yi Yang
School of Pharmacy, East China University of Science and Technology
Co-authored papers
4
Kang Zhang
College of Animal Science and Technology, Guangxi University
Co-authored papers
4
Yarui Diao
Duke University Medical Center
Co-authored papers
4
Cao Fang
University of California
Co-authored papers
4
Hongxiu Yu
Co-authored papers
3
Huilin Zhou
Co-authored papers
3
Koji Taniguchi
Co-authored papers
3
Fuchu He
International Academy of Phronesis Medicine
Co-authored papers
3
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers
3
Joan Heller Brown
Co-authored papers
3
Nabeel Bardeesy
Massachusetts General Hospital
Co-authored papers
3
Pengyuan Yang
Co-authored papers
3
Xiang-Dong Fu
Co-authored papers
3
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers
3
Thomas J Begley
University at Albany
Co-authored papers
2
1 - 30